7R7-10844-19929
5 vaccinations
12 coded responses
53 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 563 / MN
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Health check-in — day 0, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-05
- 2021-01-06
- 2021-01-13
-
2021-01-20
Dose 2 — Pfizer-BioNTech
- 2021-01-20
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Oedema peripheral, Tenderness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Axillary swelling, pain, tenderness on vaccinated side.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Axillary lymph node pain and swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: GoodFree text: Axillary lymph node pain and swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Tenderness — Feeling: GoodFree text: Mild axillary lymph node swelling/tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-04-21
Survey response — 3 months, dose 2MedDRA: COVID-19, Essential hypertension — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: COVID-19, essential hypertensionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-24
Survey response — 6 months, dose 2MedDRA: COVID-19, Dyspnoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Ongoing shortness of breath from COVID infection that began 3/15/2021MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-09
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-05
-
2021-12-09
Survey response — 3 months, dose 3MedDRA: Breakthrough COVID-19, Dyspnoea, Hypertension — Feeling: Good · Be unable to do your normal daily activitiesFree text: Ongoing symptoms since breakthrough Covid infection 3/15/21. Dyspnea and hypertension.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-10
Survey response — 6 months, dose 3MedDRA: Breast pain, Lymph node pain, Muscular weakness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tender lymph nodes in vaccinated arm (left), left arm weakness associated with left breast pain.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-18
Dose 4 — Pfizer-BioNTech
-
2022-05-19
Survey response — days 1–6 daily, dose 4MedDRA: Musculoskeletal stiffness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: StiffnessMedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2022-05-22
- 2022-05-23
- 2022-05-24
- 2022-05-27
- 2022-06-01
- 2022-06-14
- 2022-06-15
- 2022-06-22
- 2022-07-01
- 2022-08-17
-
2022-11-16
Survey response — 6 months, dose 4MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: On week 6 of an upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Dose 5 — Pfizer-BioNTech
-
2022-12-10
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2022-12-11
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Redness, Itching · Headache, Fatigue or tirednessAdult check-in
-
2022-12-12
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2022-12-13
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-12-16
- 2022-12-21
- 2022-12-28
- 2023-01-04
- 2023-01-18
-
2023-03-10
Survey response — 3 months, dose 5MedDRA: Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-06-07
Survey response — 6 months, dose 5MedDRA: Skin discolouration — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-09-09 | Pfizer-BioNTech | No |
| 4 | 2022-05-18 | Pfizer-BioNTech | No |
| 5 | 2022-12-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary swelling, pain, tenderness on vaccinated side.
Systemic reaction (other): Axillary lymph node pain and swelling
Systemic reaction (other): Axillary lymph node pain and swelling
Systemic reaction (other): Mild axillary lymph node swelling/tenderness
Release 7 — 3 months, dose 2
Symptoms: COVID-19, essential hypertension
Release 9 — 6 months, dose 2
Symptoms: Ongoing shortness of breath from COVID infection that began 3/15/2021
Release 10 — 3 months, dose 3
Symptoms: Ongoing symptoms since breakthrough Covid infection 3/15/21. Dyspnea and hypertension.
Release 11 — 6 months, dose 3
Symptoms: Tender lymph nodes in vaccinated arm (left), left arm weakness associated with left breast pain.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Stiffness
Release 12 — 6 months, dose 4
Symptoms: On week 6 of an upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Breast pain | · | · | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Essential hypertension | ✓ | ✓ | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Lymph node pain | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | · | · | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release